Quidel Wins FDA Clearance for Sofia(R) hCG FIA

Quidel Corporation (NASDAQ: QDEL ), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Sofia(R) hCG fluorescent immunoassay for use on the Sofia Analyzer for the rapid, objective detection of elevated